Cargando…

Regulatory T Cells in the Pathogenesis of Graves’ Disease

Maintaining a delicate balance between the prompt immune response to pathogens and tolerance towards self-antigens and commensals is crucial for health. T regulatory (Treg) cells are pivotal in preserving self-tolerance, serving as negative regulators of inflammation through the secretion of anti-in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kustrimovic, Natasa, Gallo, Daniela, Piantanida, Eliana, Bartalena, Luigi, Lai, Adriana, Zerbinati, Nicola, Tanda, Maria Laura, Mortara, Lorenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671795/ https://www.ncbi.nlm.nih.gov/pubmed/38003622 http://dx.doi.org/10.3390/ijms242216432

Ejemplares similares

Immunological Drivers in Graves' Disease: NK Cells as a Master Switcher
por: Gallo, Daniela, et al.
Publicado: (2020)

Epidemiology, Natural History, Risk Factors, and Prevention of Graves’ Orbitopathy
por: Bartalena, Luigi, et al.
Publicado: (2020)

How Does Vitamin D Affect Immune Cells Crosstalk in Autoimmune Diseases?
por: Gallo, Daniela, et al.
Publicado: (2023)

Immunomodulatory role of vitamin D and selenium supplementation in newly diagnosed Graves’ disease patients during methimazole treatment
por: Gallo, Daniela, et al.
Publicado: (2023)

Current concepts regarding Graves’ orbitopathy
por: Bartalena, Luigi, et al.
Publicado: (2022)

Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment
por: Gallo, Daniela, et al.
Publicado: (2022)

Management of Graves’ hyperthyroidism and orbitopathy in time of COVID-19 pandemic
por: Bartalena, L., et al.
Publicado: (2020)

Cardiometabolic healthy and unhealthy obesity: does vitamin D play a role?
por: Piantanida, Eliana, et al.
Publicado: (2017)

Change in newly diagnosed Graves’ disease phenotype between the twentieth and the twenty-first centuries: meta-analysis and meta-regression
por: Ippolito, S., et al.
Publicado: (2020)

Microbiome and Prostate Cancer: A Novel Target for Prevention and Treatment
por: Kustrimovic, Natasa, et al.
Publicado: (2023)

When primary hyperparathyroidism comes as good news
por: Gallo, Daniela, et al.
Publicado: (2020)

Role of teprotumumab in the treatment of active moderate-to-severe Graves’ orbitopathy
por: Bartalena, Luigi
Publicado: (2022)

Effects of treatment modalities for Graves’ hyperthyroidism on Graves’ orbitopathy: a 2015 Italian Society of Endocrinology Consensus Statement
por: Bartalena, L., et al.
Publicado: (2015)

The Role of Oxidative Stress on the Pathogenesis of Graves' Disease
por: Žarković, Miloš
Publicado: (2012)

Simultaneous medullary and papillary thyroid cancer: two case reports
por: Dionigi, Gianlorenzo, et al.
Publicado: (2007)

Vitamin D, Chronic Migraine, and Extracranial Pain: Is There a Link? Data From an Observational Study
por: Rebecchi, Valentina, et al.
Publicado: (2021)

The Potential Role of Osteopontin in the Pathogenesis of Graves’ Ophthalmopathy
por: Lou, Heng, et al.
Publicado: (2021)

Roles of four targets in the pathogenesis of graves' orbitopathy
por: Ren, Ziqiang, et al.
Publicado: (2023)

Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement
por: Perros, P., et al.
Publicado: (2017)

Characterization of Regulatory B Cells in Graves’ Disease and Hashimoto’s Thyroiditis
por: Kristensen, Birte, et al.
Publicado: (2015)

Current and promising therapies based on the pathogenesis of Graves’ ophthalmopathy
por: Zhang, Xin, et al.
Publicado: (2023)

Does the Epstein–Barr Virus Play a Role in the Pathogenesis of Graves’ Disease?
por: Pyzik, Aleksandra, et al.
Publicado: (2019)

Gut Microbiota May Play a Significant Role in the Pathogenesis of Graves' Disease
por: Jiang, Wen, et al.
Publicado: (2021)

SLAM/SAP Decreased Follicular Regulatory T Cells in Patients with Graves' Disease
por: Geng, Lina, et al.
Publicado: (2021)

Graves of Graves' Disease, 1796—1853
por: Taylor, Selwyn
Publicado: (1986)

The Role of Adipsin, Complement Factor D, in the Pathogenesis of Graves’ Orbitopathy
por: Byeon, Hyeong Ju, et al.
Publicado: (2023)

SARS-CoV-2 vaccine-associated subacute thyroiditis: insights from a systematic review
por: Ippolito, S., et al.
Publicado: (2022)

The Role of the Microbiota in Graves’ Disease and Graves’ Orbitopathy
por: Hou, Jueyu, et al.
Publicado: (2021)

Is There Evidence for IGF1R-Stimulating Abs in Graves’ Orbitopathy Pathogenesis?
por: Krieger, Christine C., et al.
Publicado: (2020)

The critical role of m(6)A methylation in the pathogenesis of Graves' ophthalmopathy
por: Zhu, Li, et al.
Publicado: (2020)

Emerging Insights Into the Role of Epigenetics and Gut Microbiome in the Pathogenesis of Graves’ Ophthalmopathy
por: Wang, Yan, et al.
Publicado: (2022)

Graves' Disease
Publicado: (1895)

Graves’ Disease
por: Bailey, William C.
Publicado: (1886)

Graves’ disease: moving forwards
por: Lane, Laura C, et al.
Publicado: (2023)

The Influence of Juvenile Graves' Ophthalmopathy on Graves' Disease Course
por: Jankauskiene, Jurate, et al.
Publicado: (2017)

Graves’ disease and Graves’ orbitopathy following COVID-19
por: Lanzolla, G., et al.
Publicado: (2021)

Anti-nuclear autoantibodies in Graves’ disease and Graves’ orbitopathy
por: Lanzolla, G., et al.
Publicado: (2022)

Regulatory B Cells Involvement in Autoimmune Phenomena Occurring in Pediatric Graves’ Disease Patients
por: Grubczak, Kamil, et al.
Publicado: (2021)

Evaluation of the Safety of Neauvia Stimulate Injectable Product in Patients with Autoimmune Thyroid Diseases Based on Histopathological Examinations and Retrospective Analysis of Medical Records
por: Kubik, Paweł, et al.
Publicado: (2023)

Association of fibroblast growth factor 10 with the fibrotic and inflammatory pathogenesis of Graves’ orbitopathy
por: Jang, Sun Young, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nns6r9bm2eq90kuofn2gqs2008